Democratizing hedge fund level analysis tools for everyone
Name | Pyridam Farma Tbk |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
Rejuve Global Investment PT. Ltd | 60.46 | 60.2 |
Public < 5% | 34.45 | 34.71 |
PT. Asuransi Jiwa Starinvestama | 5.1 | 5.09 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Derma Products | 0.0% | 0.0% |
Pharmaceutical Products, Esthetic and Toll Products and Toll Manufacturing Services | 98.4% | 93.1% |
Medical Equipment | 1.6% | 6.9% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 2.21 | # 13 / 15 |
EV_EBITDA | -442.40 | --- / 15 |
PER | -14.31 | --- / 15 |
PBV | 8.16 | # 14 / 15 |
DER | 7.00 | # 14 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | -15.4 | --- / 15 |
ROA % | -6.2 | --- / 15 |
ROE % | -56.9 | --- / 15 |
Year | DPS | Yield [%] |
---|---|---|
2019 | 0.9 | 0.4 |
Timeframe | Performance |
---|---|
1W % | 23.9 |
1Mo % | 132.9 |
3Mo % | 157.1 |
1Yr % | 409.3 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |
KAEF | -7.05 | 2.84 T | 14.19 T | 8,673 B | 365 B | -409 B |